A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial design
Article in BMC Pulmonary Medicine (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in BMC Pulmonary Medicine (May 2024)
Article in Cureus (February 2024)
Article in Talanta (September 2023)